Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update | Journal of Clinical Oncology
Figure 3 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
2018 ASCO/CAP summary recommendations [original recommendations and... | Download Scientific Diagram
Pathologist's Corner – Dr. Hon on Breast Cancer Tissue Handling and Updates for Her-2 Testing
Brittany Harvey on X: "Listen to the latest @ASCO Guidelines podcast episode to hear co-chairs @awolff and @DrKimAllison discuss this ASCO-CAP HER2 testing guideline update with me, including the implications for clinicians
Summary of ASCO/CAP HER2 testing recommendations 2007 and 2013 | Download Table
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/ CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer | Virchows Archiv
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows | BMC Medical Genomics | Full Text
![PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b66331181b2eafa14b6e478dcc7fced0c7917993/3-Table1-1.png "PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar")
PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar
Second act for HER2, in gastric cancers - CAP TODAY
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology
Le linee guida ASCO/CAP 2018
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
HER2 IHC and Her2 FISH Criteria Under the 2007 and the 2013 ASCO/CAP... | Download Table
What's New in the 2020 Update to the CAP/ASCO ER/PR Testing Guidelines in Breast Cancer?
The concordance between IHC and ISH for HER-2 testing in breast cancer in Nakhon Pathom Hospital, Thailand, based on the ASCO/CAP 2018 guidelines: a retrospecti
PPT - HER2 Testing in Breast Cancer: 2013 ASCO/CAP HER2 Guideline Update PowerPoint Presentation - ID:6109259
ASCO 2020: HER2 Reclassification - Agendia Inc.
Q&A column - CAP TODAY
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines.,JAMA Oncology - X-MOL
HER2 spectrum of expression according to ASCO/CAP guidelines. HER2-low... | Download Scientific Diagram
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer
ASCO 2022 – Standing ovation and hope. - Cerba Research
Identification of challenges and a framework for implementation of the AMP/ ASCO/CAP classification guidelines for reporting somatic variants - ScienceDirect
Implementation of the 2018 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort - ScienceDirect
